Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls
Recruitment status was Not yet recruiting
The investigators expect to find higher levels of both classical and minor antiphospholipid (APL) antibodies among the stroke cases. Furthermore, the investigators expect to find not only classical APLA but also minor antibodies.
The investigators believe that minor antibodies have a major role in the hypercoagulability state.
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
|Official Title:||Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls.|
Serum samples of Stroke patients withdrawned within 36 hrs since stroke evoked. Healthy controls
|Study Start Date:||December 2011|
|Estimated Study Completion Date:||September 2012|
|Estimated Primary Completion Date:||March 2012 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT01487746
|Contact: Yair Levy, Prof.||firstname.lastname@example.org,|
|Contact: Narin N Carmel, B.Scemail@example.com|
|Meir health center||Not yet recruiting|